The article focuses on gene therapy for heart diseases. It is stated that heart failure (HF) is one of the major cause of morbidity and mortality throughout the world. Genetic therapies for the modification of heart diseases include protecting the myocardium by enhanced antioxidant gene expression. It is stated that gene delivery interventions reduce the diastolic calcium levels in the cytosol.